Clinical outcomes associated with the use of oral semaglutide in an adult population with type 2 diabetes in Canada: a prospective real-world study (PIONEER REAL Canada)

被引:0
|
作者
Reichert, S. M. [1 ,2 ]
Amadid, H. [3 ]
Braae, U. C. [3 ]
Bradley, R. M. [4 ]
Kim, J. [5 ]
Soo, V. [6 ]
Yale, J. -F. [7 ]
Jain, A. [8 ]
机构
[1] Western Univ, Schulich Sch Med & Dent, Dept Family Med, London, ON, Canada
[2] Western Univ, Schulich Sch Med & Dent, Ctr Studies Family Med, London, ON, Canada
[3] Novo Nordisk AS, Soborg, Denmark
[4] Novo Nordisk Inc, Mississauga, ON, Canada
[5] Univ Calgary, Dept Family Med, Calgary, AB, Canada
[6] Western Univ, Dept Family Med, London, ON, Canada
[7] McGill Univ, McGill Univ Hlth Ctr, Montreal, PQ, Canada
[8] Univ British Columbia, Div Endocrinol & Metab, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
668
引用
收藏
页码:S338 / S339
页数:2
相关论文
共 50 条
  • [1] Use of once-daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: A multicentre, prospective real-world study (PIONEER REAL Canada)
    Jain, Akshay B.
    Reichert, Sonja M.
    Amadid, Hanan
    Braae, Uffe C.
    Bradley, Ryan M.
    Kim, James W.
    Soo, Victoria
    Yale, Jean-Francois
    DIABETES OBESITY & METABOLISM, 2024, 26 (05): : 1799 - 1807
  • [2] Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
    Kick, Anastas
    M'Rabet-Bensalah, Khadija
    Acquistapace, Flavio
    Amadid, Hanan
    Ambuhl, Robert A.
    Braae, Uffe Christian
    Item, Flurin
    Schultes, Bernd
    Zuger, Thomas
    Rudofsky, Gottfried
    DIABETES THERAPY, 2024, 15 (03) : 623 - 637
  • [3] Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study
    van Houtum, William
    Schrombges, Patrick
    Amadid, Hanan
    van Bon, Arianne C.
    Braae, Uffe C.
    Hoogstraten, Charlotte
    Herrings, Hans
    DIABETES THERAPY, 2024, 15 (08) : 1749 - 1768
  • [4] Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study
    Anastas Kick
    Khadija M’Rabet-Bensalah
    Flavio Acquistapace
    Hanan Amadid
    Robert A. Ambühl
    Uffe Christian Braae
    Flurin Item
    Bernd Schultes
    Thomas Züger
    Gottfried Rudofsky
    Diabetes Therapy, 2024, 15 : 623 - 637
  • [5] PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice
    Catrina, Sergiu-Bogdan
    Amadid, Hanan
    Braae, Uffe C.
    Dereke, Jonatan
    Ekberg, Neda Rajamand
    Klanger, Boris
    Jansson, Stefan
    DIABETES THERAPY, 2024, 15 (09) : 2079 - 2095
  • [6] Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
    Rudofsky, Gottfried
    Amadid, Hanan
    Braae, Uffe Christian
    Catrina, Sergiu-Bogdan
    Kick, Anastas
    Mandavya, Kabirdev
    Roslind, Klaus
    Saravanan, Ponnusamy
    van Houtum, William
    Jain, Akshay B.
    DIABETES THERAPY, 2025, 16 (01) : 73 - 87
  • [7] PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan
    Suzuki, Ryo
    Amadid, Hanan
    Major-Pedersen, Atheline
    Yabe, Daisuke
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (08) : 1047 - 1056
  • [8] PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice
    Yabe, Daisuke
    Hamamoto, Yoshiyuki
    Kawanami, Daiji
    Nishimura, Rimei
    Terauchi, Yasuo
    Amadid, Hanan
    Braae, Uffe Christian
    Major-Pedersen, Atheline
    Suzuki, Ryo
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (11) : 1566 - 1577
  • [9] PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 Diabetes
    Saravanan, Ponnusamy
    Bell, Heather
    Braae, Uffe Christian
    Collins, Edward
    Deinega, Alisa
    Dhatariya, Ketan
    Machell, Alena
    Trent, Antonia
    Strzelecka, Anna
    ADVANCES IN THERAPY, 2024, 41 (11) : 4266 - 4281
  • [10] PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes
    Manti, Roberta
    De Cosmo, Salvatore
    Desenzani, Paolo
    Ferrara, Lidia
    Girelli, Angela
    Memoli, Giuseppe
    Bisio, Alessandro
    Braae, Uffe Christian
    Deinega, Alisa
    Berra, Cesare
    PIONEER REAL Italy Investigators, Massimiliano
    DIABETES THERAPY, 2025, : 1019 - 1032